BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32247370)

  • 1. Prodromal PD: A new nosological entity.
    Schaeffer E; Postuma RB; Berg D
    Prog Brain Res; 2020; 252():331-356. PubMed ID: 32247370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.
    Fereshtehnejad SM; Montplaisir JY; Pelletier A; Gagnon JF; Berg D; Postuma RB
    Mov Disord; 2017 Jun; 32(6):865-873. PubMed ID: 28429825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodromal Parkinson's disease--using REM sleep behavior disorder as a window.
    Postuma RB
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S1-4. PubMed ID: 24262156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in markers of prodromal Parkinson disease.
    Postuma RB; Berg D
    Nat Rev Neurol; 2016 Oct; 12(11):622-634. PubMed ID: 27786242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.
    Pilotto A; Heinzel S; Suenkel U; Lerche S; Brockmann K; Roeben B; Schaeffer E; Wurster I; Yilmaz R; Liepelt-Scarfone I; von Thaler AK; Metzger FG; Eschweiler GW; Postuma RB; Maetzler W; Berg D
    Mov Disord; 2017 Jul; 32(7):1025-1034. PubMed ID: 28509336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.
    Barber TR; Lawton M; Rolinski M; Evetts S; Baig F; Ruffmann C; Gornall A; Klein JC; Lo C; Dennis G; Bandmann O; Quinnell T; Zaiwalla Z; Ben-Shlomo Y; Hu MTM
    Sleep; 2017 Aug; 40(8):. PubMed ID: 28472425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodromal features for Parkinson's disease--baseline data from the TREND study.
    Gaenslen A; Wurster I; Brockmann K; Huber H; Godau J; Faust B; Lerche S; Eschweiler GW; Maetzler W; Berg D
    Eur J Neurol; 2014 May; 21(5):766-72. PubMed ID: 24612314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of the Rapid Progression in Prodromal Parkinson's Disease: A Longitudinal Follow-Up Study.
    Liu P; Chen L; He X; Mao L
    Gerontology; 2024; 70(6):595-602. PubMed ID: 38565088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-motor symptoms in premotor phase of Parkinson disease].
    Takahashi K
    Rinsho Shinkeigaku; 2013; 53(11):974-6. PubMed ID: 24291850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection.
    Swallow DM; Lawton MA; Grosset KA; Malek N; Smith CR; Bajaj NP; Barker RA; Ben-Shlomo Y; Burn DJ; Foltynie T; Hardy J; Morris HR; Williams N; Wood NW; Grosset DG;
    J Parkinsons Dis; 2016 Mar; 6(2):289-300. PubMed ID: 27003780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of Nonmotor Symptoms in Parkinson's Disease.
    Konno T; Al-Shaikh RH; Deutschländer AB; Uitti RJ
    Int Rev Neurobiol; 2017; 133():259-289. PubMed ID: 28802922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tract-Based Spatial Statistics Reveal Lower White Matter Integrity Specific to Idiopathic Rapid Eye Movement Sleep Behavior Disorder as a Proxy for Prodromal Parkinson's Disease.
    Ohlhauser L; Smart CM; Gawryluk JR
    J Parkinsons Dis; 2019; 9(4):723-731. PubMed ID: 31498130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
    Siderowf A; Concha-Marambio L; Lafontant DE; Farris CM; Ma Y; Urenia PA; Nguyen H; Alcalay RN; Chahine LM; Foroud T; Galasko D; Kieburtz K; Merchant K; Mollenhauer B; Poston KL; Seibyl J; Simuni T; Tanner CM; Weintraub D; Videnovic A; Choi SH; Kurth R; Caspell-Garcia C; Coffey CS; Frasier M; Oliveira LMA; Hutten SJ; Sherer T; Marek K; Soto C;
    Lancet Neurol; 2023 May; 22(5):407-417. PubMed ID: 37059509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microstructural changes in patients with Parkinson disease and REM sleep behavior disorder: depressive symptoms versus non-depressed.
    Ghazi Sherbaf F; Rahmani F; Jooyandeh SM; Aarabi MH
    Acta Neurol Belg; 2018 Sep; 118(3):415-421. PubMed ID: 29442234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson's Disease: Longitudinal Data from the PPMI Study.
    Koros C; Simitsi AM; Papagiannakis N; Bougea A; Prentakis A; Papadimitriou D; Pachi I; Beratis I; Stanitsa E; Angelopoulou E; Antonelou R; Bregianni M; Lourentzos K; Papageorgiou SG; Bonakis A; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2023; 13(5):811-818. PubMed ID: 37424476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Prodromal Parkinson's Disease as Defined by MDS Research Criteria among Elderly Patients Undergoing Colonoscopy.
    Skorvanek M; Ladomirjakova Z; Han V; Lesko N; Feketeova E; Jarcuskova D; Repkova B; Spisak P; Urbancikova Z; Vargova A; Gombosova L; Zakuciova M; Veseliny E; Trebuna F; Mechirova E; Gdovinova Z
    J Parkinsons Dis; 2017; 7(3):481-489. PubMed ID: 28387681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of clinical markers in prodromal Parkinson's disease and dementia with Lewy bodies: a multicentre study.
    Joza S; Hu MT; Jung KY; Kunz D; Stefani A; Dušek P; Terzaghi M; Arnaldi D; Videnovic A; Schiess MC; Hermann W; Lee JY; Ferini-Strambi L; Lewis SJG; Leclair-Visonneau L; Oertel WH; Antelmi E; Sixel-Döring F; Cochen De Cock V; Liguori C; Liu J; Provini F; Puligheddu M; Nicoletti A; Bassetti CLA; Bušková J; Dauvilliers Y; Ferri R; Montplaisir JY; Lawton M; Kim HJ; Bes F; Högl B; Šonka K; Fiamingo G; Mattioli P; Lavadia ML; Suescun J; Woo KA; Marelli S; Martens KE; Janzen A; Plazzi G; Mollenhauer B; Fernandes M; Li Y; Cortelli P; Figorilli M; Cicero CE; Schaefer C; Guiraud L; Lanza G; Gagnon JF; Sunwoo JS; Ibrahim A; Girtler N; Trenkwalder C; Baldelli L; Pelletier A; Postuma RB;
    Brain; 2023 Aug; 146(8):3258-3272. PubMed ID: 36881989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for prodromal Parkinson's disease in the general community: a sleep-based approach.
    Postuma RB; Pelletier A; Berg D; Gagnon JF; Escudier F; Montplaisir J
    Sleep Med; 2016 May; 21():101-5. PubMed ID: 27448479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.